Home Cart Sign in  
Chemical Structure| 71203-35-5 Chemical Structure| 71203-35-5

Structure of ML141
CAS No.: 71203-35-5

Chemical Structure| 71203-35-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ML141 is a reversible and selective inhibitor of Cdc42 GTPase with IC50 of 200 nM.

Synonyms: CID-2950007

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of ML141

CAS No. :71203-35-5
Formula : C22H21N3O3S
M.W : 407.49
SMILES Code : O=S(C1=CC=C(N2N=C(C3=CC=CC=C3)CC2C4=CC=C(OC)C=C4)C=C1)(N)=O
Synonyms :
CID-2950007
MDL No. :MFCD05987165
InChI Key :QBNZBMVRFYREHK-UHFFFAOYSA-N
Pubchem ID :2950007

Safety of ML141

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H320-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of ML141

GPCR

Isoform Comparison

Biological Activity

Target
  • Cdc42-subclass

    cdc42, IC50:200 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
RAW264.7 cells 10 µM 2 hours Suppression of Cdc42 reduced the LPS-stimulated expressions of IL6, TNF-α, and IL1β, indicating that ML141 inhibited M1-type macrophage polarization. PMC11047801
THP1 cells 10 µM 2 hours Inhibition of Cdc42 activities reduced the expression of M1 polarization markers CD86 and CD64, while increasing the expression of M2 polarization marker CD206, indicating that ML141 promoted M2-type macrophage polarization. PMC11047801
vascular smooth muscle cells 10 µM 20 hours ML141 reduced OPN elevation in LRP6-deficient VSM PMC4490945

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice hepatic ischemia-reperfusion injury model peritoneal injection 10 mg/kg every 12 hours, twice Inhibition of Cdc42 significantly alleviated hepatic ischemia-reperfusion injury, inhibited the infiltration of monocyte-derived macrophages, reduced M1 macrophages, and increased M2 macrophages. PMC11047801
BALB/c mice BALB/c mice Intraperitoneal injection 1 mg/ml daily for 3 weeks To investigate the effect of Cdc42 inhibition on podocyte apoptosis, the results showed that Cdc42 inhibition led to increased podocyte apoptosis and proteinuria. PMC4823952

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.45mL

0.49mL

0.25mL

12.27mL

2.45mL

1.23mL

24.54mL

4.91mL

2.45mL

References

 

Historical Records

Categories